Universities Canada: Follow the Leader Scholarship Program

The purpose of the scholarship program is to encourage academic excellence and the pursuit of higher education among students living in the Greater Toronto Area who are directly affected by Multiple Sclerosis (MS); provide the path and framework for scholarship recipients to become the MS leaders of the future and to strengthen the pool of scientific, engineering, math and technology students who consider a focus on MS to be part of their career of choice.

Favoured:

Listing Details

Organization Name

Universities Canada

juno.aucc.ca/wes/hes.aspx?pg=934&oth=0003442015

Organization Mandate

As the national voice for Canadian universities, Universities Canada (formerly the Association of Universities and Colleges of Canada) represents 97 public and private not-for-profit universities and university degree-level colleges.

It is a membership organization providing university presidents with a unified voice and a forum for collective action.

Countries

Regions

North America, Central America, South America, Caribbean, Western Europe, Eastern Europe, Central Asia, East Asia, Southeast Asia, South Asia, Middle East, North Africa, Central Africa, Western Africa, Eastern Africa, Southern Africa, Oceania, Antarctica

Subcategory

undergraduate

Subject - funding opportunities

Science, Technology, Engineering, Math

Application deadline

April of each year

Amount of the award

25,000

Eligibility - nationality

Canada

Eligibility

Live and attend high school in the Greater Toronto Area (Toronto, Durham, Halton, Peel, York Regions).

Have at least an 85% (or equivalent) average over the last 3 terms of available marks.

Plan on enrolling full-time in a Canadian, American or Foreign university, specifically in a Science, Technology, Engineering or Math (STEM) program.

Live in a family in which an immediate member (self, sibling or parent/guardian) is directly affected by MS or an allied disease (neuromyelitis optica (NMO), transverse myelitis (TM), and acute disseminated encephalomyelitis (ADEM)).

Visit Report Claim